Browse All
Displaying 1 - 2 of 2
Author:Weber, Martin Kappos, Ludwig Hauser, Stephen Schneble, Hans-Martin Wang, Qing Giovannoni, Gavin
Session Name:S46: MS Therapeutics and Clinical Decision Making
Topic:MS and Inflammatory Disease
Program Number:S46.003
Author Institution:Institute of Neuropathology and Department of Neurology, University Medical Centre, Göttingen, Germany, and Fraunhofer-Institute for Translational Medicine and Pharmacology ITMP, Göttingen, Germany, Gottingen, Germany Research Center for Clinical Neuroimmunology and Neuroscience, University Hospital Basel, University of Basel, Basel, Switzerland, Basel, Switzerland UCSF Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA, San Francisco, CA F. Hoffmann-La Roche Ltd, Basel, Switzerland, Basel, Switzerland Queen Mary University of London, London, UK, London, United Kingdom
Author:Hoffmann, Olaf Schreiber, Herbert Klotz, Luisa Weber, Martin Weiss, Cordula Ziemssen, Tjalf
Session Name:P8: MS Therapeutics 2
Program Number:P8.013
Author Institution:St.Josefs-Krankenhaus Potsdam, Potsdam, Germany Neurological Practice Center Ulm, Ulm-Donau, Germany Uniklinik Münster, Münster, Germany University Medical Center Goettingen, Goettinger, Germany Novartis Pharma GmbH, Nuremberg, Germany University Clinic Dresden, Dresden, Germany
